GLPG3970

Cat. No. M40967

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

GLPG3970 is a first-in-class salt-inducible kinase SIK2/SIK3 inhibitor for studies related to inflammatory and autoimmune diseases such as psoriasis.

Molecular Weight	504.50
Formula	C25H27F3N4O4
CAS Number	2403733-82-2
Form	Solid
Solubility (25°C)	DMSO 90 mg/mL
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related Salt-inducible Kinase Products
SIKs-IN-1 SIKs-IN-1 inhibitor.
MR22 MR22 is a potent pan-SIK (salt-inducible kinase) inhibitor.
SIK2-IN-1 SIK2-IN-1 is a potent SIK2 inhibitor over other AMPK kinases.
YKL-06-062 YKL-06-062 is a second-generation salt-inducible kinase (SIK) inhibitor with an IC50 of 2.12 nM/1.40 nM/2.86 nM for SIK1, SIK2 and SIK3, respectively.
MRT199665 MRT199665 is a potent and ATP-competitive, selective MARK/SIK/AMPK inhibitor with IC50s of 2/2/3/2 nM, 10/10 nM, and 110/12/43 nM for MARK1/MARK2/MARK3/MARK14, AMPKα1/AMPKα2, and SIK1/SIK2/SIK3, respectively. MRT199665 causes apoptosis in MEF2C-activated human acute myeloid leukemias (AML) cells. MRT199665 inhibits the phosphorylation of SIK substrate CRTC3 at S370.

Catalog